Komori
Jmdc (4483) · FactAdvancedLatest Earnings presentation (2026-08-05): "Restated"

Revenue and earnings growth underpinned by three businesses

First written in FY2020-Q3. 26 of 32 entries say "Advanced", first in FY2020-Q3. Latest entry: 2026-08-05.

32entries
7years
11from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2020-Q3 – FY2025-H12020: 420202021: 320212022: 420222023: 420232024: 320242025: 220252026: 122026
Same theme, other companies
Performance and profitability trends, including growth and changes in revenue and profitA theme 620 companies write about · 47 as a headwind · 763 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 126 companies compared. The sentences above are computed from all 126.Comparing 200 of the theme's 899 threads.
Full recordFilings, disclosures and news, newest first
  2. FY2026AdvancedAnnual report

    「As a result, revenue for the current consolidated fiscal year was ¥50,462 million, operating profit was ¥10,521 million, and EBITDA was ¥13,178 million, representing increases in both revenue and profit.」

    Full-year revenue was ¥50,462 million, operating profit was ¥10,521 million, and EBITDA was ¥13,178 million, up 20.9%, 20.7%, and 20.5%, respectively, year on year.
  4. FY2026-H1AdvancedAnnual report

    「As a result, revenue for the consolidated interim period was ¥23,080 million, operating profit was ¥4,025 million, and EBITDA was ¥5,524 million, representing increases in both revenue and profit.」

    The two continuing-operations segments, health big data and telemedicine, generated interim revenue of ¥23,080 million, operating profit of ¥4,025 million, and EBITDA of ¥5,524 million. Year on year, revenue increased 24.4%, operating profit increased 27.7%, and EBITDA increased 23.3%.
  5. FY2025ReframedAnnual report

    「During the consolidated fiscal year, the business operated by Noa Medical relating to support for dispensing pharmacies was classified as a discontinued operation. Revenue, operating profit, and EBITDA relating to this business have been presented as discontinued operations for both the consolidated fiscal year and the comparative preceding consolidated fiscal year.」

    The business structure was reorganized from one based on the former three businesses to one centered on the two reporting segments of health big data and telemedicine, with dispensing-pharmacy support classified as a discontinued operation. Revenue from continuing operations was ¥41,722 million and EBITDA was ¥10,932 million.
  6. FY2025-H1AdvancedAnnual report

    「As a result, revenue for the consolidated interim period was ¥19,197 million, operating profit was ¥3,250 million, and EBITDA was ¥4,619 million, representing higher revenue but lower profit.」

    Revenue increased 39.6% year on year and EBITDA increased 39.9%, while operating profit declined 9.8%. Across the three businesses, revenue increased but profit declined, with EBITDA rising to ¥4,619 million.
  7. FY2024AdvancedAnnual report

    「As a result, revenue for the consolidated fiscal year was ¥32,381 million, operating profit was ¥7,006 million, and EBITDA was ¥9,471 million, representing increases in both revenue and profit.」

    Full-year revenue was ¥32,381 million, operating profit was ¥7,006 million, and EBITDA was ¥9,471 million, up 16.4%, 18.2%, and 22.7%, respectively, year on year.
  8. FY2024-Q3AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated third quarter was ¥22,281 million, operating profit was ¥5,667 million, and EBITDA was ¥6,188 million, representing increases in both revenue and profit.」

    Revenue for the cumulative third quarter was ¥22,281 million, operating profit was ¥5,667 million, and EBITDA was ¥6,188 million, up 14.0%, 40.7%, and 16.1%, respectively, year on year.
  9. FY2024-Q2AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated second quarter was ¥13,746 million, operating profit was ¥3,602 million, and EBITDA was ¥3,303 million, representing increases in both revenue and profit.」

    Revenue for the cumulative second quarter was ¥13,746 million, operating profit was ¥3,602 million, and EBITDA was ¥3,303 million, up 14.0%, 63.2%, and 11.7%, respectively, year on year.
  10. FY2024-Q1AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated first quarter was ¥6,698 million, operating profit was ¥2,546 million, and EBITDA was ¥1,679 million, representing increases in both revenue and profit.」

    First-quarter revenue was ¥6,698 million, operating profit was ¥2,546 million, and EBITDA was ¥1,679 million, up 16.0%, 135.5%, and 10.4%, respectively, year on year.
  11. FY2023AdvancedAnnual report

    「As a result, revenue for the consolidated fiscal year was ¥27,809 million, operating profit was ¥5,926 million, and EBITDA was ¥7,716 million, representing increases in both revenue and profit.」

    Full-year revenue was ¥27,809 million, operating profit was ¥5,926 million, and EBITDA was ¥7,716 million, up 27.5%, 23.9%, and 20.4%, respectively, year on year.
  12. FY2023-Q3AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated third quarter was ¥19,542 million, operating profit was ¥4,028 million, and EBITDA was ¥5,332 million, representing increases in both revenue and profit.」

    Revenue for the cumulative third quarter was ¥19,542 million, operating profit was ¥4,028 million, and EBITDA was ¥5,332 million, up 24.6%, 18.3%, and 16.4%, respectively, year on year.
  13. FY2023-Q2AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated second quarter was ¥12,060 million, operating profit was ¥2,207 million, and EBITDA was ¥2,956 million, representing increases in both revenue and profit.」

    Revenue for the cumulative second quarter was ¥12,060 million, operating profit was ¥2,207 million, and EBITDA was ¥2,956 million, up 26.3%, 27.4%, and 19.6%, respectively, year on year.
  14. FY2023-Q1AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated first quarter was ¥5,776 million, operating profit was ¥1,081 million, and EBITDA was ¥1,521 million, representing increases in both revenue and profit.」

    First-quarter revenue was ¥5,776 million, operating profit was ¥1,081 million, and EBITDA was ¥1,521 million, up 27.5%, 31.3%, and 30.7%, respectively, year on year.
  15. FY2022AdvancedAnnual report

    「As a result, revenue for the consolidated fiscal year was ¥21,814 million, operating profit was ¥4,800 million, and EBITDA was ¥6,411 million, representing increases in both revenue and profit.」

    Full-year revenue was ¥21,814 million, operating profit was ¥4,800 million, and EBITDA was ¥6,411 million, up 30.1%, 29.9%, and 31.7%, respectively, year on year.
  16. FY2022-Q3AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated third quarter was ¥15,679 million, operating profit was ¥3,417 million, and EBITDA was ¥4,580 million, representing increases in both revenue and profit.」

    Revenue for the cumulative third quarter was ¥15,679 million, operating profit was ¥3,417 million, and EBITDA was ¥4,580 million, up 35.1%, 41.0%, and 39.5%, respectively, year on year.
  17. FY2022-Q2AdvancedAnnual report

    「As a result, revenue for the cumulative consolidated second quarter was ¥9,550 million, operating profit was ¥1,740 million, and EBITDA was ¥2,472 million, representing increases in both revenue and profit.」

    Revenue for the cumulative second quarter was ¥9,550 million, operating profit was ¥1,740 million, and EBITDA was ¥2,472 million, up 36.9%, 57.2%, and 48.6%, respectively, year on year.
  18. FY2022-Q1AdvancedAnnual report

    「Revenue for the three months ended [the current] first quarter was ¥4,530 million, operating profit was ¥826 million, and EBITDA was ¥1,164 million, representing increases in both revenue and profit.」

    First-quarter revenue was ¥4,530 million, operating profit was ¥826 million, and EBITDA was ¥1,164 million, up 41.0%, 131.4%, and 89.6%, respectively, year on year.
  19. FY2021-Q3AdvancedAnnual report

    「As a result, revenue for the nine months ended [the current] third quarter was ¥11,606 million, operating profit was ¥2,424 million, and EBITDA was ¥3,284 million, representing increases in both revenue and profit.」

    Revenue increased 34.1% year on year to ¥11,606 million, operating profit increased 63.7% to ¥2,424 million, and EBITDA increased 45.9% to ¥3,284 million.
  20. FY2021-Q2AdvancedAnnual report

    「As a result, revenue for the six months ended [the current] second quarter was ¥6,975 million, operating profit was ¥1,107 million, and EBITDA was ¥1,664 million, representing increases in both revenue and profit.」

    Discloses second-quarter cumulative results showing year-on-year increases of 24.0% in revenue, 24.7% in operating profit and 26.4% in EBITDA, with increases in both revenue and profit.
  21. FY2021-Q1AdvancedAnnual report

    「Revenue for the three months ended [the current] first quarter was ¥3,212 million, operating profit was ¥357 million, and EBITDA was ¥614 million, representing increases in both revenue and profit.」

    Discloses first-quarter results showing year-on-year increases of 25.6% in revenue, 34.2% in operating profit and 27.9% in EBITDA.
  22. FY2020AdvancedAnnual report

    「As a result, revenue for the consolidated fiscal year was ¥12,158 million, operating profit was ¥2,215 million, and EBITDA was ¥3,245 million, representing increases in both revenue and profit.」

    Discloses full-year revenue of ¥12,158 million, operating profit of ¥2,215 million and EBITDA of ¥3,245 million, showing year-on-year increases in both revenue and profit.
  23. FY2020-Q3AdvancedAnnual report

    「As a result, revenue for the nine months ended [the current] third quarter was ¥8,654 million, operating profit was ¥1,481 million, and EBITDA was ¥2,251 million, representing increases in both revenue and profit.」

    Reports year-on-year increases in revenue, operating profit and EBITDA as the combined results of the three businesses.
Moved together

"Expanding the Database and Business Platform Through Acquisitions" moved the same way as this thread, in the same document, in 20 of its 27 moves.

20151311109★123456
  1. ★This thread
  2. 1Expanding the Database and Business Platform Through Acquisitions20×
  3. 2Strengthening staffing and organizational capabilities to capture business opportunities15×
  4. 3Repayment of Borrowings Through New Share Issuance and Securing Investment Capacity13×
  5. 4Priority on Retained Earnings and Future Dividend Policy11×
  6. 5Expansion of Health Insurance Societies, PeP Up and Data Utilization for Companies10×
  7. 6Expansion of Contracted Radiologists and Contracted Medical Institutions9×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Jmdc's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the Earnings presentation of 2026-08-05: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Revenue and earnings growth underpinned by three businesses | JMDC Inc. (4483) | Komori